Daniel Edward Lumsden

Daniel Edward Lumsden

Auto-generated profile, based on publicly available information

Daniel Edward Lumsden

Paediatric Neurosciences, Guy's and St Thomas’ NHS Foundation Trust, London, UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EMEsther Meyer
Esther Meyer
KCKeren Carss
Keren Carss
JRJulia Rankin
Julia Rankin
JNJohn M E Nichols
John M E Nichols
DGDetelina Grozeva
Detelina Grozeva
MKManju A Kurian
Manju A Kurian

1 March 2013 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
DLDaniel E Lumsden
Daniel E Lumsden
MKMargaret Kaminska
Margaret Kaminska
HGHortensia Gimeno
Hortensia Gimeno
KTKylee Tustin
Kylee Tustin
LBLesley Baker
Lesley Baker
JLJean‐Pierre Lin
Jean‐Pierre Lin
Aim: The aim of this study was to examine the impact of dystonia aetiology and duration, contracture, and age at deep brain stimulation (DBS) surgery on outcome in a cohort of children with medically refractory, disabling primary, secondary‐static, or secondary‐progressive dystonias, including neurodegeneration with brain iron accumulation (NBIA).Method: Dystonia severity was assessed using the Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS) motor score at baseline and 6 and 12 months postoperatively in a cohort of 70 consecutive children undergoing DBS between June 2005 and July 2011.Results: Two children (3%) received unilateral DBS for hemidystonia and were excluded and five (7%) developed infections requiring part‐DBS removal within 6 months, leaving 63 children (90%) undergoing bilateral DBS for follow‐up (34 males, 29 females; mean age at surgery for the whole group 10y 4mo, SD 4y 2mo, range 1–14y). Seventeen children were classified with primary dystonia: mean age 12 years 11 months, SD 4 years 6 months range 4 years 6 months to 17 years 3 months; 28 as having secondary‐static dystonia: mean age 10 years 2 months, SD 4 years 9 months (range 3y 3mo–20y); five as having secondary‐progressive dystonia: mean age 8 years 11 months, SD 3 years 9 months (range 5y 5mo–13y 1mo); and 13 as having NBIA dystonia: mean age 10 years 2 months, SD 3 years 11 months (range 1–14y). Children with primary dystonias demonstrated greater improvements in BFMDRS motor score than those in the other aetiological categories (Kruskal–Wallis test, p<0.001), which correlated negatively with dystonia duration and more strongly still against the ratio of dystonia duration normalized to age at surgery (DD/AS ratio) at 1 year (Spearman's rank correlation coefficient 0.4752 and −0.599 respectively). A similar significant negative correlation was found in the secondary‐static dystonia group between outcome at 1 year and DD/AS ratio (−0.461). Poorer outcome in secondary dystonia coincided with the absence of a period of normal motor development in comparison with the primary dystonia group. A significant improvement in BFMDRS motor score was seen in the NBIA group at 6, but not 12 months (Wilcoxon signed rank test p=0.028, p=0.85 respectively). No reduction in efficacy was seen in children with a musculoskeletal deformity at the time of surgery.Conclusion: Response to pallidal DBS in the treatment of dystonia declines with the proportion of life lived with dystonia in primary and secondary dystonia. Other intrinsic factors reduce the median magnitude of reduction in secondary dystonia after DBS. DBS should be offered early, preferably within 5 years of onset, to maximize benefits and reduce the childhood experience of dystonia, including musculoskeletal deformity. Other multidimensional assessments are required to understand how DBS improves the lives of children with dystonia.

3 March 2014 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
JLJean-Pierre Lin
Jean-Pierre Lin
DLD. E. Lumsden
D. E. Lumsden
HGHortensia Gimeno
Hortensia Gimeno
MKMargaret Kaminska
Margaret Kaminska
Introduction and methods The impact of dystonia in childhood is poorly understood. We report our experience of referrals between 2005 and 2012. Results Of 294/315 assessable children, 15/294 had pure spasticity, leaving 279/294 with dystonia classified as primary (30/279: 10.7%); primary-plus (19/279: 6.8%) and secondary (230/279: 82.4%) dystonia, including heredodegenerative dystonia (29/279: 10.3%); 150/279 (53.7%) with cerebral palsy and 51/279 (18.2%) acquired brain injury. Definitive diagnoses were available in 222/294 (79.6%), but lower in primary/primary-plus compared with secondary groups (11/49 vs 211/230: Fisher's exact test p0.05); dystonia-onset age was 3 (0.5–7.0) for primary/primary-plus and 0.25 (0.08–0.8) in the secondary/CP groups. Dystonia duration at referral was 4.75 years (3.0–10.33) for primary/primary-plus groups and 7.83 (5.4–11) in the secondary group. The mean (interquartile range) proportion of life lived with dystonia, derived as dystonia duration normalised to age was 0.68 (0.31–0.96); 0.59 (0.35–0.8); 0.75 (0.62–0.95)and 0.9 (0.92–0.99) for primary, primary-plus, heredodegenerative and secondary-static dystonias respectively. Only 91/279 (32.6%) experienced a period of normal motor development. Carers perceived dystonia deterioration in 168/279 (60.2%), stabilisation in 88/279 (31.5%) and improvement in 23/279 (8.2%). Dystonia occurred in 26/225 (11.6%) siblings: 14/26 secondary and 5/26 heredodegenerative dystonia. Comorbidities were identified in 176/279 (63.1%) cases. Gross Motor Function Classification System (GMFCS) levels I–III were commoner in primary/primary-plus (37/49: 75%) compared with secondary/CP (29/230: 13%) cases, χ2 p<0.0001). Discussion In this selective cohort, childhood dystonia is severe, presenting early before worsening without remission. Secondary dystonias spend a higher proportion of life living with dystonia and lower functional capacity. Despite referral bias, services offering neurosurgical interventions and health service planning agencies should understand the context and predicament of life with childhood dystonia.

1 January 2017 in European Journal of Paediatric Neurology
Verified
Journal Article
Open access
MKMargaret Kaminska
Margaret Kaminska
SPSarah Perides
Sarah Perides
DLDaniel E. Lumsden
Daniel E. Lumsden
VNVasiliki Nakou
Vasiliki Nakou
RSRichard Selway
Richard Selway
JLJean-Pierre Lin
Jean-Pierre Lin
Deep brain stimulation (DBS) has been increasingly used for primary and secondary movement disorders in children and young people. Reports of hardware related complications have been sparse for this population and from small cohorts of patients. We report DBS complications from a single large DBS centre with 10 year experience. Data was collected as a prospective audit and additionally from a questionnaire on recharging of the stimulators. 129 patients with a minimum 6 months follow up were identified, mean age10.8 y (range 3.0-18.75), mean follow up 3.3y (range 0.5-10.3), weight 10.4-94.2 kg, 126 new implants (92 Activa RC) and 69 revisions for reasons other than infection. 26 patients were 7y or younger. Surgical site infections (SSI) rates were 10.3% for new implants and revisions, lower 8.6% for new Activa RC and even lower, 4.7%, for new Activa RC in patients under 7y (1/21). SSI occurred within first 6 months and necessitated total system removal in 86% of those infected. Electrode/extension problems were recorded in 18.4% of patients, fracture in 4.6% malfunction in 7.7%, short extension 3.8% and electrode migration in 2.3%. Other complications involved clinically silent intracranial bleed in 1 patient, skin erosions (2.3%), unexpected switching off in 18.7% of Soletra/Kinetra and 3.4% of Activa RC, transient seroma at IPG site in postoperative period (8%). Of the 48 returned recharging questionnaires, 38% of families required recharger replacement and 23% experienced frequent problems maintaining connection during recharging. However, 83% of responders considered recharging not at all or only a little care burden. We identified lower than previously reported DBS infection rates particularly for patients under 7 years, but relatively high incidence of technical problems with electrodes, extensions and in particular recharging. This has to be considered when offering DBS for children with movement disorders.

1 January 2016 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
NLNatasha Yuan-Kim Liow
Natasha Yuan-Kim Liow
HGHortensia Gimeno
Hortensia Gimeno
DLDaniel Edward Lumsden
Daniel Edward Lumsden
JMJennifer Marianczak
Jennifer Marianczak
MKMargaret Kaminska
Margaret Kaminska
JLJean-Pierre Sao-Ming Lin
Jean-Pierre Sao-Ming Lin

1 July 2016 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
DLDaniel E. Lumsden
Daniel E. Lumsden
MKMargaret Kaminska
Margaret Kaminska
STStephen Tomlin
Stephen Tomlin
JLJean-Pierre Lin
Jean-Pierre Lin